Viewing Study NCT03069469


Ignite Creation Date: 2025-12-24 @ 10:54 PM
Ignite Modification Date: 2026-01-03 @ 12:31 PM
Study NCT ID: NCT03069469
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-18
First Post: 2017-02-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor
Sponsor: Deciphera Pharmaceuticals, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module